Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Save on this medicine
Same active ingredient — pay up to 70% less
These brands contain the same active ingredient (Trimetazidine Dihydrochloride). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Angirid MR
Rx35 mg • Tablet (Modified Release)
Indications & Uses
Angirid MR is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
The recommended dose of Trimetazidine Dihydrochloride is 35 mg twice daily, or alternatively 20 mg three times a day with meals. Treatment benefit should be reviewed after three months, and Trimetazidine should be stopped if no improvement is seen.
Side Effects
Vastadin MR is safe and well tolerated. Common side effects seen with Vastadin MR include dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia.
Cautions & Contraindications
Warnings & Precautions
Vastadin MR does not relieve an angina attack that is already underway, and it should not be relied on as the first treatment when angina is unstable. It is likewise not used to treat a heart attack (myocardial infarction).
Contraindications
Trimetazidine should not be used by anyone who is hypersensitive to the active substance or to any of the excipients in the formulation. It is also unsuitable for patients with Parkinson's disease, parkinsonian symptoms, tremors, restless legs syndrome, or severe renal impairment.